Salem Investment Counselors Inc Amgen Inc Transaction History

Salem Investment Counselors Inc

$3.24 Billion
Q3 2024

A detailed history of Salem Investment Counselors Inc transactions in Amgen Inc stock. As of the latest transaction made, Salem Investment Counselors Inc holds 24,271 shares of AMGN stock, worth $6.29 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

24,271

Previous 23,589 2.89%

Holding current value

$6.29 Million

Previous $7.37 Million 6.11%

% of portfolio

0.24%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $210,997 - $230,093	682 Added 2.89%	24,271 $7.82 Million
Q2 2024 Jul 11, 2024	BUY	$262.75 - $319.31 $282,981 - $343,896	1,077 Added 4.78%	23,589 $7.37 Million
Q1 2024 Apr 11, 2024	BUY	$268.87 - $324.56 $920,342 - $1.11 Million	3,423 Added 17.93%	22,512 $6.4 Million
Q4 2023 Jan 16, 2024	BUY	$255.7 - $288.46 $258,768 - $291,921	1,012 Added 5.6%	19,089 $5.5 Million
Q3 2023 Oct 04, 2023	BUY	$218.65 - $271.46 $3.7 Million - $4.59 Million	16,915 Added 1455.68%	18,077 $4.86 Million
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $31,711 - $37,498	148 Added 14.6%	1,162 $257,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $3,838 - $4,678	17 Added 1.71%	1,014 $245,000
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $8,529 - $9,619	-38 Reduced 3.67%	997 $225,000
Q2 2022 Aug 17, 2022	BUY	$230.71 - $256.74 $10,381 - $11,553	45 Added 4.55%	1,035 $252,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $148,226 - $163,977	-676 Reduced 40.58%	990 $239,000
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $3,977 - $4,552	20 Added 1.22%	1,666 $375,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $15,495 - $18,155	-73 Reduced 4.25%	1,646 $350,000
Q2 2021 Aug 17, 2021	BUY	$233.58 - $259.14 $185,228 - $205,498	793 Added 85.64%	1,719 $419,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $22,412 - $26,118	101 Added 12.24%	926 $230,000
Q4 2020 Feb 17, 2021	BUY	$216.38 - $257.67 $36,135 - $43,030	167 Added 25.38%	825 $190,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $1,582 - $1,941	8 Added 1.23%	658 $155,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $9,112 - $12,085	50 Added 8.33%	650 $132,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $12,187 - $14,603	-70 Reduced 10.45%	600 $116,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $28,839 - $33,805	-173 Reduced 20.52%	670 $123,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $152,473 - $171,870	843 New	843 $175,000
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $150,391 - $175,554	-843 Closed	0 $0
Q3 2017 Nov 16, 2017	BUY	$167.29 - $191.0 $141,025 - $161,013	843	843 $157,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.

Account

Salem Investment Counselors Inc Amgen Inc Transaction History